High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

TRIAL DESIGN: The QoLKAMON study evaluated quality of life, efficacy and treatment safety in HIV patients receiving lopinavir/ritonavir in monotherapy (MT) versus continuing combined antiretroviral triple treatment with a boosted protease inhibitor (TT). METHODS: This was a 24-week, open-label, mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquau, Juan, Hidalgo-Tenorio, Carmen, Montes, María Luisa, Romero-Palacios, Alberto, Vergas, Jorge, Sanjoaquín, Isabel, Hernández-Quero, José, Aguirrebengoa, Koldo, Orihuela, Francisco, Imaz, Arkaitz, Ríos-Villegas, María José, Flores, Juan, Fariñas, María Carmen, Vázquez, Pilar, Galindo, María José, García-Mercé, Isabel, Lozano, Fernando, de los Santos, Ignacio, de Jesus, Samantha Elizabeth, García-Vallecillos, Coral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896909/
https://www.ncbi.nlm.nih.gov/pubmed/29649309
http://dx.doi.org/10.1371/journal.pone.0195068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896909/
https://www.ncbi.nlm.nih.gov/pubmed/29649309
http://dx.doi.org/10.1371/journal.pone.0195068

Ejemplares similares